🇺🇸 FDA
Patent

US 10980780

Methods and compositions of anti-inflammatory drug and dicer activator for treatment of neuronal diseases

granted A61KA61K31/415A61K31/416

Quick answer

US patent 10980780 (Methods and compositions of anti-inflammatory drug and dicer activator for treatment of neuronal diseases) held by NEUROSENSE THERAPEUTICS LTD. expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
NEUROSENSE THERAPEUTICS LTD.
Grant date
Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/415, A61K31/416, A61K31/496, A61P